批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1943/03/23 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/12/15 |
SUPPL-46(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/09/27 |
SUPPL-44(补充) |
Approval |
|
STANDARD
|
|
|
| 2018/06/28 |
SUPPL-39(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide |
STANDARD
|
|
|
| 2017/01/13 |
SUPPL-38(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2009/01/26 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/01/16 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2001/06/15 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2000/07/10 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1999/04/23 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1992/04/22 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1988/12/23 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1988/11/08 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1988/07/26 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
| 1988/07/26 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1988/07/26 |
SUPPL-13(补充) |
Approval |
Efficacy-New Indication |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE; 剂型/给药途径:TABLET;ORAL; 规格:1.5MG;5MG; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 005213 |
001 |
NDA |
HYCODAN |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
TABLET;ORAL |
1.5MG;5MG |
Prescription |
Yes |
No |
AA |
1988/07/26
|
GENUS |
| 091528 |
001 |
ANDA |
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
TABLET;ORAL |
1.5MG;5MG |
Discontinued |
No |
No |
AA |
2011/04/20
|
NOVEL LABS INC |
| 207176 |
001 |
ANDA |
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
TABLET;ORAL |
1.5MG;5MG |
Prescription |
No |
Yes |
AA |
2017/08/07
|
AVANTHI INC |
>>>活性成分:HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE; 剂型/给药途径:SYRUP;ORAL; 规格:1.5MG/5ML;5MG/5ML; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 088008 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
1983/03/03
|
PHARMOBEDIENT |
| 088017 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
1983/07/05
|
ACTAVIS MID ATLANTIC |
| 005213 |
002 |
NDA |
HYCODAN |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
Yes |
No |
AA |
1988/07/26
|
GENUS |
| 040613 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Discontinued |
No |
No |
AA |
2008/02/08
|
GENUS LIFESCIENCES |
| 203535 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
2017/02/13
|
NOVEL LABS INC |
| 205731 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
No |
AA |
2017/02/15
|
PADAGIS US |
| 207487 |
001 |
ANDA |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
SYRUP;ORAL |
1.5MG/5ML;5MG/5ML |
Prescription |
No |
Yes |
AA |
2017/02/21
|
ABHAI LLC |